Septerna (SEPN) Tax Provisions (2024 - 2026)

Septerna's (SEPN) quarterly Tax Provisions came in at $337000.0 in Q1 2026, up 2708.33% quarter-over-quarter from $12000.0 in Q4 2025.

Septerna (SEPN) Tax Provisions (2024 - 2026) Analysis & Trends

Septerna's Tax Provisions history runs 3 years deep, the most recent figure standing at $337000.0 for Q1 2026.

On a quarterly basis, Tax Provisions changed N/A year-over-year to $337000.0 in Q1 2026; TTM through Mar 2026 was $349000.0, a 286.63% increase from a year earlier, with the FY2025 full-year figure at $12000.0, up 102.41% from the prior year.
Tax Provisions rose to $337000.0 in Q1 2026 per SEPN's latest filing, from $12000.0 in the prior quarter.
Across five years, Tax Provisions topped out at $337000.0 in Q1 2026 and bottomed at -$160000.0 in Q4 2024.
The 3-year median for Tax Provisions is $52500.0 (2024), against an average of $42500.0.
Biggest YoY gain for Tax Provisions was 107.5% in 2025; the steepest drop was 107.5% in 2025.
Year by year, Tax Provisions stood at -$160000.0 in 2024, then soared by 107.5% to $12000.0 in 2025, then soared by 2708.33% to $337000.0 in 2026.
Per Business Quant, the three latest SEPN Tax Provisions figures stand at $337000.0 (Q1 2026), $12000.0 (Q4 2025), and -$160000.0 (Q4 2024).

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	125,146.46
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	31.86 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	188,883.60
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	221.50 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	179.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Septerna	1.50 Bn	1.50 Bn	-	337,000.00

Download Data